Breast Cancer :: Contrast agent puts new light on diagnosing breast cancer
Harvard Medical School researchers are working on a new, simpler way to distinguish malignant tumors from non-cancerous masses when screening for breast cancer.
Harvard Medical School researchers are working on a new, simpler way to distinguish malignant tumors from non-cancerous masses when screening for breast cancer.
Cleveland Clinic researchers report that the drug torcetrapib, despite raising high density lipoprotein cholesterol (HDL) or the “good” cholesterol by more than 60%, did not slow the progression of plaque buildup in the coronary arteries as measured using an ultrasound probe.
Novartis to launch its own branded version of a leading multiple sclerosis therapy through agreement with Bayer Schering Pharma.
Using the massive computer-simulation power of the San Diego Supercomputer Center (SDSC) at UC San Diego, researchers are zeroing in on the causes of Parkinson’s disease, Alzheimer’s disease, rheumatoid arthritis and other diseases.
An international study using ultrasound technology has found that the most potent cholesterol-lowering drug is also effective at halting early changes in the blood vessels that can lead to atherosclerosis.
In India, Tripura Government has sounded an alert against bird flu in the wake of reports of the disease in neighbouring Bangladesh.
Genetics and family history play a large role in a person?s risk for heart disease, but factors in diet, lifestyle and the environment are also thought to influence susceptibility to the disease.
Heart problems in children are quite different from those in adults, and four studies presented today at the American College of Cardiology?s 56th Annual Scientific Session look at how pediatric cardiologists take different approaches to better understand and manage cardiovascular disease in this population, including insights into fundamental cardiac mechanisms and testing of new procedures.
The use of medicines to fight cardiovascular disease has been a primary focus of research in this area for the past several decades, as combinations of interventions and medicinal therapy have gradually begun to increase long-term survival rates.
Researchers at the University at Buffalo have described a novel pathway by which estradiol, the primary estrogen in humans, aids in maintaining bone density, a function critical to avoiding osteoporosis.